Your browser doesn't support javascript.
loading
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Cree, Bruce A C; Bennett, Jeffrey L; Kim, Ho Jin; Weinshenker, Brian G; Pittock, Sean J; Wingerchuk, Dean M; Fujihara, Kazuo; Paul, Friedemann; Cutter, Gary R; Marignier, Romain; Green, Ari J; Aktas, Orhan; Hartung, Hans-Peter; Lublin, Fred D; Drappa, Jorn; Barron, Gerard; Madani, Soraya; Ratchford, John N; She, Dewei; Cimbora, Daniel; Katz, Eliezer.
Afiliação
  • Cree BAC; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Electronic address: bruce.cree@ucsf.edu.
  • Bennett JL; School of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
  • Kim HJ; Research Institute and Hospital of National Cancer Center, Seoul, South Korea.
  • Weinshenker BG; Mayo Clinic, Rochester, MN, USA.
  • Pittock SJ; Mayo Clinic, Rochester, MN, USA.
  • Wingerchuk DM; Mayo Clinic, Scottsdale, AZ, USA.
  • Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan; Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.
  • Paul F; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Cutter GR; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Marignier R; Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Lyon University Hospital, Lyon, France.
  • Green AJ; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
  • Aktas O; Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Hartung HP; Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Lublin FD; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Drappa J; Viela Bio, Gaithersburg, MD, USA.
  • Barron G; MedImmune, Cambridge, UK.
  • Madani S; Viela Bio, Gaithersburg, MD, USA.
  • Ratchford JN; Viela Bio, Gaithersburg, MD, USA.
  • She D; Viela Bio, Gaithersburg, MD, USA.
  • Cimbora D; Viela Bio, Gaithersburg, MD, USA.
  • Katz E; Viela Bio, Gaithersburg, MD, USA.
Lancet ; 394(10206): 1352-1363, 2019 10 12.
Article em En | MEDLINE | ID: mdl-31495497
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article